BLACKROCK HEALTH SCIENCES TR's ticker is BME and the CUSIP is 09250W107. A total of 26 filers reported holding BLACKROCK HEALTH SCIENCES TR in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $798,000 | -1.1% | 20,994 | +1.1% | 0.01% | 0.0% |
| Q2 2019 | $807,000 | +2.9% | 20,771 | +5.4% | 0.01% | -12.5% |
| Q1 2019 | $784,000 | +11.0% | 19,709 | +1.7% | 0.01% | 0.0% |
| Q4 2018 | $706,000 | -14.6% | 19,385 | -0.4% | 0.01% | 0.0% |
| Q3 2018 | $827,000 | +30.9% | 19,467 | +18.8% | 0.01% | +14.3% |
| Q2 2018 | $632,000 | +15.5% | 16,384 | +4.7% | 0.01% | +16.7% |
| Q1 2018 | $547,000 | +26.6% | 15,644 | +32.0% | 0.01% | 0.0% |
| Q4 2017 | $432,000 | +18.4% | 11,848 | +18.3% | 0.01% | +20.0% |
| Q3 2017 | $365,000 | +22.5% | 10,019 | +23.2% | 0.01% | +25.0% |
| Q2 2017 | $298,000 | -85.8% | 8,132 | +65.3% | 0.00% | -20.0% |
| Q4 2014 | $2,100,000 | 0.0% | 4,920 | -14.0% | 0.01% | 0.0% |
| Q2 2014 | $2,100,000 | -0.8% | 5,720 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $2,117,000 | +4.4% | 5,720 | 0.0% | 0.01% | -16.7% |
| Q4 2013 | $2,027,000 | +0.6% | 5,720 | -11.8% | 0.01% | -14.3% |
| Q2 2013 | $2,015,000 | – | 6,487 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nova R Wealth, Inc. | 497,037 | $22,625,000 | 19.33% |
| PRIMORIS WEALTH ADVISORS, LLC | 8,555 | $391,000 | 0.36% |
| Diversified, LLC | 16,186 | $737,000 | 0.30% |
| CORRADO ADVISORS, LLC | 9,285 | $423,000 | 0.26% |
| Cornerstone Advisory, LLC | 35,218 | $1,603,000 | 0.24% |
| Ahrens Investment Partners LLC | 11,200 | $510,000 | 0.16% |
| Waterfront Wealth Inc. | 8,211 | $386,000 | 0.14% |
| Claro Advisors LLC | 8,725 | $221,000 | 0.08% |
| Eudaimonia Partners, LLC | 8,494 | $387,000 | 0.07% |
| SOA Wealth Advisors, LLC. | 4,640 | $211,000 | 0.05% |